CSIR-IICT, NIIST, Suven Pharma sign MoU for Molnupiravir – Express Pharma fi

0
8

The CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, the CSIR-National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram and Suven Pharmaceuticals have entered into an MoU for the process technology transfer and manufacturing of the anti-COVID drug Molnupiravir.

The anti-viral drug was initially developed for the treatment of influenza and has been repurposed to treat COVID-19.

According to a study published in the journal ‘Nature Microbiology,’ the drug can completely suppress the COVID virus transmission within 24 hours, the CSIR-IICT said in a release.

The synthetic process know-how for Molnupiravir was sourced from CSIR-NIIST and the process to scale it up was successfully carried out by CSIR-IICT, it said.

The complete technology know-how will be transferred to SPL and the company, in turn, would manufacture and launch the drug in the market as an effective medication for COVID infected patients, it said.

As per the agreement, CSIR-IICT would also provide the process know-how for the manufacture of new anti-COVID drug 2 -DG to treat moderate and severe COVID infected patients to reduce their oxygen dependency, the release added.

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.

Related title:
CSIR-IICT, NIIST, Suven Pharma sign MoU for Molnupiravir
Suven Pharma inks non-exclusive licencing pact with IICT, NIIST for 2-DG & Molnupiravir process tech

en

Keywords:

Pharmaceutical industry,Council Of Scientific And Industrial Research–Indian Institute Of Chemical Technology (CSIR-IICT),Suven Life Sciences Ltd.,Council Of Scientific And Industrial Research–National Institute for Interdisciplinary Science and Technology (CSIR–NIIST),Pharmaceutical industry, Council Of Scientific And Industrial Research–Indian Institute Of Chemical Technology (CSIR-IICT), Suven Life Sciences Ltd., Council Of Scientific And Industrial Research–National Institute for Interdisciplinary Science and Technology (CSIR–NIIST),,

QU’EN PENSEZ-VOUS?

[comment]

PUB

Laisser un commentaire, votre avis compte!

[gs-fb-comments] [comment-form]